Matrix metalloproteinases as attractive therapeutic targets for chronic pain: a narrative review

XY Dai, L Liu, FH Song, SJ Gao, JY Wu, DY Li… - International Journal of …, 2024 - Elsevier
Chronic pain constitutes an abnormal pain state that detrimentally affects the quality of life,
daily activities, occupational performance, and stability of mood. Despite the prevalence of …

Investigating the potential of GalR2 as a drug target for neuropathic pain

K Rich, S Rehman, J Jerman, G Wilkinson - Neuropeptides, 2023 - Elsevier
Neuropathic pain is a chronic and debilitating condition characterised by episodes of
hyperalgesia and allodynia. It occurs following nerve damage from disease, inflammation or …

Disruption of C/EBPβ-Clec7a axis exacerbates neuroinflammatory injury via NLRP3 inflammasome-mediated pyroptosis in experimental neuropathic pain

D Wu, Y Zhang, C Zhao, Q Li, J Zhang, J Han… - Journal of Translational …, 2022 - Springer
Background Growing evidence shows that C-Type Lectin Domain Containing 7A (Clec7a)
may be involved into neuroinflammatory injury of various neurological diseases. However …

The identification of blood biomarkers of chronic neuropathic pain by comparative transcriptomics

B Islam, J Stephenson, B Young, M Manca… - Neuromolecular …, 2022 - Springer
In this study, we recruited 50 chronic pain (neuropathic and nociceptive) and 43 pain-free
controls to identify specific blood biomarkers of chronic neuropathic pain (CNP). Affymetrix …

Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain

J Gao, C Tang, LW Tai, Y Ouyang, N Li… - Journal of Pain …, 2018 - Taylor & Francis
Background Pro-resolving mediators (PRMs) are considered as emerging analgesics for
chronic pain. Maresin 1 (MaR1) is a newly identified member of PRMs, and recent studies …

Transcriptomics in pain research: insights from new and old technologies

H Starobova, SWA Himaya, RJ Lewis, I Vetter - Molecular Omics, 2018 - pubs.rsc.org
Despite significant advances in our understanding of the molecular basis of pain, the precise
contributions of individual genes to our perception of this primal sensation remains …

Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways

SL Bourke, EG Suarez, B Islam… - European Journal of …, 2025 - Wiley Online Library
Background Chronic neuropathic pain (CNP) is a debilitating condition, often refractory to
currently available drugs. Understanding biochemical alterations in peripheral tissues such …

Protocol for biospecimen collection and analysis within the BACPAC research program

AJ Fields, S Dudli, A Schrepf, A Kim, B Pham… - Pain …, 2023 - academic.oup.com
Abstract The Biospecimen Collection and Processing Working Group of the National
Institutes of Health (NIH) HEAL Initiative BACPAC Research Program was charged with …

Neuropeptides, substrates and inhibitors of human dipeptidyl peptidase III, experimental and computational study—A new substrate identified

Z Karačić, F Šupljika, A Tomić, L Brkljačić… - International journal of …, 2022 - Elsevier
Abstract Dipeptidyl peptidase III (DPP III) is a cytosolic, two-domain zinc-exopeptidase. It is
widely distributed in mammalian tissues, where it's involved in the final steps of normal …

Identification of the hub genes related to nerve injury-induced neuropathic pain

K Wang, D Yi, Z Yu, B Zhu, S Li, X Liu - Frontiers in Neuroscience, 2020 - frontiersin.org
Background The reactivity enhancement of pain sensitive neurons in the nervous system is
a feature of the pathogenesis for neuropathic pain (NP), yet the underlying mechanisms …